AbbVie Inc (ABBV) has a current Price-to-Book (P/B) ratio of -153.40. Compared to its 3-year average P/B ratio of -122.57, the current P/B ratio is approximately 25.15% higher. Relative to its 5-year average P/B ratio of -64.70, the current P/B ratio is about 137.07% higher. AbbVie Inc (ABBV) has a Forward Free Cash Flow (FCF) yield of approximately 4.86%. Compared to its 3-year average FCF yield of 6.59%, the current FCF yield is approximately -26.25% lower. Relative to its 5-year average FCF yield of 7.59%, the current FCF yield is about -35.98% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ABBV competitors is 5.07, providing a benchmark for relative valuation. AbbVie Inc Corp (ABBV.N) exhibits a P/S ratio of 6.25, which is 23.4% above the industry average. Given its robust revenue growth of 10.04%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ABBV increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ABBV in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ABBV currently overvalued or undervalued?

What is AbbVie Inc (ABBV) fair value?

ABBV's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of AbbVie Inc (ABBV) is between 196.69 to 260.10 according to relative valuation method.

How does ABBV's valuation metrics compare to the industry average?

The average P/S ratio for ABBV's competitors is 5.07, providing a benchmark for relative valuation. AbbVie Inc Corp (ABBV) exhibits a P/S ratio of 6.25, which is 23.40% above the industry average. Given its robust revenue growth of 10.04%, this premium appears unsustainable.

What is the current P/B ratio for AbbVie Inc (ABBV) as of Mar 03 2026?

As of Mar 03 2026, AbbVie Inc (ABBV) has a P/B ratio of -153.40. This indicates that the market values ABBV at -153.40 times its book value.

What is the current FCF Yield for AbbVie Inc (ABBV) as of Mar 03 2026?

As of Mar 03 2026, AbbVie Inc (ABBV) has a FCF Yield of 4.86%. This means that for every dollar of AbbVie Inc's market capitalization, the company generates 4.86 cents in free cash flow.

What is the current Forward P/E ratio for AbbVie Inc (ABBV) as of Mar 03 2026?

As of Mar 03 2026, AbbVie Inc (ABBV) has a Forward P/E ratio of 16.63. This means the market is willing to pay $16.63 for every dollar of AbbVie Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for AbbVie Inc (ABBV) as of Mar 03 2026?

As of Mar 03 2026, AbbVie Inc (ABBV) has a Forward P/S ratio of 6.25. This means the market is valuing ABBV at $6.25 for every dollar of expected revenue over the next 12 months.

ABBV Valuation